Ign Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 10.00 K
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
About Ign Biotech
Ign Biotech Private Limited (IBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 October 2020 (Four years and three months 28 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Mohan Nithyakalyani, Gautam Seetharaman, and Anusha Sunderrajan serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73200TN2020PTC138593
-
Company No.
138593
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Oct 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Ign Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Nithyakalyani
|
Director | 12-Oct-2020 | Current |
|
Gautam Seetharaman
|
Director | 12-Oct-2020 | Current |
|
Anusha Sunderrajan
|
Director | 26-Aug-2021 | Current |
Financial Performance of Ign Biotech.
Enhance accessibility to Ign Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ign Biotech?
Unlock access to Ign Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cell2cure Therapies Private LimitedMohan Nithyakalyani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ign Biotech?
Ign Biotech has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ign Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ign Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.